Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Analysts who follow Asset Entities Inc. know the real story hides in its disclosures—subscriber churn, influencer contract costs, and AE.360.DDM platform growth. If you have searched for “Asset Entities SEC filings explained simply” or “Asset Entities quarterly earnings report 10-Q filing,” this page delivers every document in one place. From an 8-K material events explained on a new Discord partnership to an Asset Entities annual report 10-K simplified, you can stop scrolling through EDGAR and start focusing on the numbers that matter.
Begin with our AI-powered summaries. The engine parses each filing in seconds, extracting premium subscription revenue, Ternary payment volume, and cash-flow shifts, then flags them in plain English. Need Asset Entities Form 4 insider transactions real-time alerts, a concise earnings report filing analysis, or details from the proxy statement executive compensation section? Stock Titan posts them as soon as the SEC accepts the upload, giving you unmatched real-time visibility into Asset Entities insider trading Form 4 transactions.
Because Asset Entities operates in fast-moving social-media markets, its filings feature novel metrics—Discord server KPIs, influencer revenue shares, and platform R&D spend. Our tools connect each metric to the form that reveals it: 10-Q segments outline platform revenue, 8-K notices flag sudden partnership news, and Asset Entities executive stock transactions Form 4 show when leaders add to holdings. Understanding Asset Entities SEC documents with AI lets you compare quarters, track material changes, and see trends before they surface elsewhere. Welcome to streamlined due diligence for a company redefining digital community engagement.
Strive, Inc. announced a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive definitive materials to vote on the proposed transaction.
The notice includes a forward-looking statements caution, identifies potential proxy solicitation participants, and clarifies this is not an offer or solicitation. Related documents will be available free of charge at SEC.gov and the companies’ investor relations websites.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The notice reiterates standard forward‑looking statement cautions and directs investors to SEC filings for details.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, with related Information Statement/Proxy Statement/Prospectus materials, including versions filed on August 6, 2025 and October 10, 2025. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
The communication emphasizes that it is not an offer to sell or solicit an offer to buy securities. Investors are urged to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S‑4 to register the Class A common stock it would issue in the transaction, which will include an information statement of Strive, a proxy statement for Semler Scientific stockholders, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward‑looking statements subject to risks and uncertainties referenced in prior SEC filings of both companies. It also notes that directors, officers, and certain employees of both companies may be deemed participants in the proxy solicitation.
This notice reiterates that it is not an offer or solicitation to sell or buy securities. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction. The registration will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication contains forward-looking statement disclaimers and directs investors to SEC filings for risks and details, including Strive’s S-4 and related reports and Semler Scientific’s 10-K and 10-Qs. It notes that directors and officers of both companies may be deemed participants in the proxy solicitation and provides links to obtain documents free of charge. It also states this is not an offer to sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, and a combined Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval.
Investors are directed to review the Registration Statement and related materials when available on the SEC’s website and each company’s investor relations pages. The notice includes standard forward‑looking statement cautions and clarifies this is not an offer or solicitation to buy or sell securities.
Strive, Inc. reposted a communication on X in connection with its proposed business combination with Semler Scientific, Inc. (SMLR). The notice includes a forward‑looking statements caution and explains that Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The materials will be available free of charge on the SEC’s website and the companies’ investor sites. The communication states it is not an offer or solicitation, and identifies that Strive, Semler Scientific, and certain directors, officers, and employees may be deemed participants in the proxy solicitation for the proposed transaction.
Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction; the S-4 will include an information statement of Strive, a proxy statement of Semler, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval. The materials will be available free on the SEC’s website and the companies’ investor sites. The communication includes forward-looking statement cautions and states it is not an offer or solicitation. Directors, officers, and employees of both companies may be participants in the proxy solicitation, with their interests to be described in the forthcoming proxy/prospectus.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice emphasizes forward-looking statement cautions and references Strive’s Form S-4, which registers Class A common stock to be issued in connection with the transaction. A combined Information Statement/Proxy Statement/Prospectus will be provided to Semler Scientific stockholders to seek their approval.
Investors are directed to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and each company’s investor relations pages. The communication also notes that directors and officers of both companies may be deemed participants in the proxy solicitation, with their interests to be described in the forthcoming joint materials. It reiterates a standard no offer or solicitation disclaimer, stating that any sale of securities will occur only by means of a prospectus meeting Securities Act requirements.
Strive, Inc. reposted a communication on X regarding its proposed business combination with Semler Scientific. The message emphasizes that any forward-looking statements involve risks and uncertainties.
Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction, and an Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek approval. Investors are urged to read the Registration Statement and related materials when available on the SEC website. This communication does not constitute an offer to sell securities.
Strive, Inc. and Semler Scientific announced a proposed business combination. Strive has filed a Form S-4 to register the Class A common stock it would issue in the transaction. The combined information statement, proxy statement, and prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication includes a standard caution that any forward-looking statements involve risks and uncertainties, and references each company’s SEC filings for additional risk factors. It also notes that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation.
This is not an offer or solicitation to buy or sell securities. Investors can access the Registration Statement and related materials free of charge at the SEC’s website and the companies’ investor relations pages.
FAQ
What is the current stock price of Strive (ASST)?
What is the market cap of Strive (ASST)?
